Acute Respiratory Illnesses in Children in the SARS-CoV-2 Pandemic: Prospective Multicenter Study

Zaid Haddadin1, Jennifer E Schuster2, Andrew J Spieker3

  • 1Department of Pediatrics, Vanderbilt University Medical Center, Vanderbilt University, Nashville, Tennessee.

Pediatrics
|May 14, 2021
PubMed

Insights

Community mitigation measures significantly reduced respiratory syncytial virus (RSV) and influenza cases in children during the COVID-19 pandemic. These interventions led to a sharp decline in acute respiratory illnesses (ARIs) and virus detection rates.

Area of Science:

  • Pediatric infectious diseases
  • Epidemiology
  • Public health interventions

Background:

  • Nonpharmaceutical interventions (NPIs) are crucial for controlling viral acute respiratory illnesses (ARIs).
  • The impact of COVID-19 pandemic mitigation strategies on other respiratory viruses like RSV and influenza remains an important area of study.
  • Understanding these impacts is vital for future public health planning and resource allocation.

Purpose of the Study:

  • To assess the frequency of respiratory syncytial virus (RSV) and influenza-associated acute respiratory illnesses (ARIs) in children before and during the COVID-19 pandemic.
  • To evaluate the effectiveness of community mitigation measures implemented during the COVID-19 pandemic on the incidence of RSV and influenza.
  • To analyze changes in ARI surveillance data in response to public health interventions.

Main Methods:

  • Prospective, multicenter, population-based surveillance of ARIs in children across 7 US cities.
  • Collection and molecular testing of respiratory samples from children in emergency departments and inpatient settings.
  • Statistical analysis using generalized linear mixed-effects models to assess the association between community mitigation and viral case data.

Main Results:

  • A total of 25,415 children were enrolled and tested; 25% were RSV-positive and 14% were influenza-positive.
  • Following the introduction of community mitigation measures in 2020, a significant decrease in eligible ARI subjects and viral detection was observed, with no RSV or influenza detected from April 5 to April 30, 2020.
  • Compared to 2016-2019, there was a 63.9% and 45.8% reduction in the odds of testing positive for RSV and influenza, respectively, during the 2020 mitigation period.

Conclusions:

  • Rapid declines in pediatric ARI cases and proportions of RSV and influenza were observed across 7 US cities between March and April 2020.
  • These declines are likely attributable to community mitigation measures implemented against SARS-CoV-2.
  • The findings underscore the significant impact of public health interventions on the epidemiology of common respiratory viruses.
Abstract

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
599
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
498
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
263
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
439
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
1.1K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.7K